ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Interaction between coronary lesion complexity and coronary microvascular dysfunction in the prognosis of NSTEMI patients.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prognostic value of the American College of Cardiology/American Heart Association (ACC/AHA) lesion classification in NSTEMI remains insufficiently investigated, especially regarding its interaction with coronary microvascular disease (CMD).
methodsIn 2212 NSTEMI patients, we evaluated lesion complexity by applying the modified ACC/AHA classification system and then measured post-PCI angio-IMR. The primary endpoint was major adverse cardiovascular events (MACE) at 2 years.
resultsPatients with complex lesions demonstrated substantially elevated 2-year MACE rates compared to those with simple lesions (13.5% vs 7.5%, P < 0.001). Lesion complexity independently predicted MACE [HR 1.48 (95% CI (1.09-2.00)), P = 0.011]. Notably, the addition of lesion classification to a model containing the GRACE score and other clinical factors significantly improved risk prediction [C-index 0.708 (95% CI (0.672-0.744)) vs 0.693 (95% CI (0.655-0.730)), P = 0.017)]. Among non-CMD patients, complex lesions were correlated with the higher MACE incidence (10.50% vs 6.20%, P = 0.002), whereas no significant difference was observed in CMD patients (37.80% vs 26.00%, P = 0.166). Notably, CMD showed a strong association with complex lesions [OR 1.74 (95% CI (1.22-2.48)), P = 0.002]. Mediation analysis indicated that CMD accounted for 17% of the total effect of lesion complexity on MACE [proportion of effect 0.17 (95% CI (0. 07-0.39)), P = 0.002].
conclusionsThe American College of Cardiology/American Heart Association lesion classification effectively stratifies risk in non-ST-segment elevation myocardial infarction, particularly among patients without coronary microvascular disease. Coronary microvascular disease is independently associated with complex coronary lesions and mediates approximately 17% of their adverse prognostic impact on major adverse cardiovascular events.
Indexed as
Identifiers
41284050What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.